These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
New York
|
|
13-1432060
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
Large accelerated filer
|
|
þ
|
Accelerated filer
|
¨
|
|
|
|
|
|
|
|
Non-accelerated filer
|
|
¨
|
Smaller reporting company
|
¨
|
|
|
1
|
|
|
|
|
March 31, 2015
|
|
December 31, 2014
|
||||
|
ASSETS
|
|
|
|
|
||||
|
Current Assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
443,689
|
|
|
$
|
478,573
|
|
|
Trade receivables (net of allowances of $7,795 and $9,147, respectively)
|
|
525,260
|
|
|
493,768
|
|
||
|
Inventories: Raw materials
|
|
258,779
|
|
|
275,161
|
|
||
|
Work in process
|
|
19,845
|
|
|
17,705
|
|
||
|
Finished goods
|
|
257,841
|
|
|
275,863
|
|
||
|
Total Inventories
|
|
536,465
|
|
|
568,729
|
|
||
|
Deferred income taxes
|
|
17,127
|
|
|
27,709
|
|
||
|
Prepaid expenses and other current assets
|
|
232,569
|
|
|
141,248
|
|
||
|
Total Current Assets
|
|
1,755,110
|
|
|
1,710,027
|
|
||
|
Property, plant and equipment, at cost
|
|
1,713,269
|
|
|
1,766,746
|
|
||
|
Accumulated depreciation
|
|
(1,021,261
|
)
|
|
(1,046,478
|
)
|
||
|
|
|
692,008
|
|
|
720,268
|
|
||
|
Goodwill
|
|
675,484
|
|
|
675,484
|
|
||
|
Other intangible assets, net
|
|
74,717
|
|
|
76,557
|
|
||
|
Deferred income taxes
|
|
178,948
|
|
|
183,047
|
|
||
|
Other assets
|
|
130,905
|
|
|
129,238
|
|
||
|
Total Assets
|
|
$
|
3,507,172
|
|
|
$
|
3,494,621
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
||||
|
Current Liabilities:
|
|
|
|
|
||||
|
Bank borrowings and overdrafts and current portion of long-term debt
|
|
$
|
8,379
|
|
|
$
|
8,090
|
|
|
Accounts payable
|
|
215,915
|
|
|
229,866
|
|
||
|
Accrued payroll and bonus
|
|
41,350
|
|
|
71,264
|
|
||
|
Dividends payable
|
|
37,959
|
|
|
37,968
|
|
||
|
Other current liabilities
|
|
183,717
|
|
|
171,620
|
|
||
|
Total Current Liabilities
|
|
487,320
|
|
|
518,808
|
|
||
|
Long-term debt
|
|
935,170
|
|
|
934,232
|
|
||
|
Deferred gains
|
|
45,815
|
|
|
46,535
|
|
||
|
Retirement liabilities
|
|
353,748
|
|
|
354,333
|
|
||
|
Other liabilities
|
|
113,022
|
|
|
118,024
|
|
||
|
Total Other Liabilities
|
|
1,447,755
|
|
|
1,453,124
|
|
||
|
Commitments and Contingencies (Note 12)
|
|
|
|
|
||||
|
Shareholders’ Equity:
|
|
|
|
|
||||
|
Common stock 12 1/2¢ par value; authorized 500,000,000 shares; issued 115,995,113 and 115,858,190 shares as of March 31, 2015 and December 31, 2014, respectively; and outstanding 80,902,319 and 80,777,590 shares as of March 31, 2015 and December 31, 2014
|
|
14,470
|
|
|
14,470
|
|
||
|
Capital in excess of par value
|
|
135,619
|
|
|
140,008
|
|
||
|
Retained earnings
|
|
3,441,033
|
|
|
3,350,734
|
|
||
|
Accumulated other comprehensive loss
|
|
(573,315
|
)
|
|
(540,430
|
)
|
||
|
Treasury stock, at cost - 35,092,794 shares as of March 31, 2015 and 35,080,600 shares as of December 31, 2014
|
|
(1,450,490
|
)
|
|
(1,446,221
|
)
|
||
|
Total Shareholders’ Equity
|
|
1,567,317
|
|
|
1,518,561
|
|
||
|
Noncontrolling interest
|
|
4,780
|
|
|
4,128
|
|
||
|
Total Shareholders’ Equity including noncontrolling interest
|
|
1,572,097
|
|
|
1,522,689
|
|
||
|
Total Liabilities and Shareholders’ Equity
|
|
$
|
3,507,172
|
|
|
$
|
3,494,621
|
|
|
|
2
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2015
|
|
2014
|
||||
|
Net sales
|
|
$
|
774,907
|
|
|
$
|
770,224
|
|
|
Cost of goods sold
|
|
428,630
|
|
|
428,812
|
|
||
|
Gross profit
|
|
346,277
|
|
|
341,412
|
|
||
|
Research and development expenses
|
|
63,462
|
|
|
61,504
|
|
||
|
Selling and administrative expenses
|
|
120,835
|
|
|
123,733
|
|
||
|
Restructuring and other charges, net
|
|
187
|
|
|
122
|
|
||
|
Operating profit
|
|
161,793
|
|
|
156,053
|
|
||
|
Interest expense
|
|
11,095
|
|
|
11,677
|
|
||
|
Other (income) expense, net
|
|
(5,710
|
)
|
|
1,443
|
|
||
|
Income before taxes
|
|
156,408
|
|
|
142,933
|
|
||
|
Taxes on income
|
|
28,150
|
|
|
36,226
|
|
||
|
Net income
|
|
128,258
|
|
|
106,707
|
|
||
|
Other comprehensive income (loss), after tax:
|
|
|
|
|
||||
|
Foreign currency translation adjustments
|
|
(50,515
|
)
|
|
(9,396
|
)
|
||
|
Gains on derivatives qualifying as hedges
|
|
12,083
|
|
|
460
|
|
||
|
Pension and postretirement net liability
|
|
5,547
|
|
|
4,365
|
|
||
|
Other comprehensive income (loss)
|
|
(32,885
|
)
|
|
(4,571
|
)
|
||
|
Total comprehensive income
|
|
$
|
95,373
|
|
|
$
|
102,136
|
|
|
Net income per share - basic
|
|
$
|
1.58
|
|
|
$
|
1.31
|
|
|
Net income per share - diluted
|
|
$
|
1.57
|
|
|
$
|
1.30
|
|
|
Average number of shares outstanding - basic
|
|
80,654
|
|
|
81,053
|
|
||
|
Average number of shares outstanding - diluted
|
|
81,195
|
|
|
81,732
|
|
||
|
Dividends declared per share
|
|
$
|
0.47
|
|
|
$
|
0.39
|
|
|
|
3
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2015
|
|
2014
|
||||
|
Cash flows from operating activities:
|
|
|
|
|
||||
|
Net income
|
|
$
|
128,258
|
|
|
$
|
106,707
|
|
|
Adjustments to reconcile to net cash provided by operating activities:
|
|
|
|
|
||||
|
Depreciation and amortization
|
|
19,985
|
|
|
22,830
|
|
||
|
Deferred income taxes
|
|
13,932
|
|
|
8,246
|
|
||
|
(Gain) loss on disposal of assets
|
|
34
|
|
|
(811
|
)
|
||
|
Stock-based compensation
|
|
5,387
|
|
|
4,695
|
|
||
|
Pension contributions
|
|
(54,048
|
)
|
|
(5,316
|
)
|
||
|
Changes in assets and liabilities, net of Aromor acquisition:
|
|
|
|
|
||||
|
Trade receivables
|
|
(62,891
|
)
|
|
(41,569
|
)
|
||
|
Inventories
|
|
13,172
|
|
|
(591
|
)
|
||
|
Accounts payable
|
|
(3,061
|
)
|
|
(11,989
|
)
|
||
|
Accruals for incentive compensation
|
|
(27,675
|
)
|
|
(62,282
|
)
|
||
|
Other current payables and accrued expenses
|
|
20,264
|
|
|
1,096
|
|
||
|
Other assets/liabilities, net
|
|
(21,881
|
)
|
|
13,977
|
|
||
|
Net cash provided by operating activities
|
|
31,476
|
|
|
34,993
|
|
||
|
Cash flows from investing activities:
|
|
|
|
|
||||
|
Cash paid for acquisition, net of cash received (including $15 million of contingent consideration)
|
|
—
|
|
|
(102,400
|
)
|
||
|
Additions to property, plant and equipment
|
|
(19,381
|
)
|
|
(33,836
|
)
|
||
|
Proceeds from life insurance contracts
|
|
—
|
|
|
12,308
|
|
||
|
Maturity of net investment hedges
|
|
—
|
|
|
(472
|
)
|
||
|
Proceeds from disposal of assets
|
|
1,450
|
|
|
2,042
|
|
||
|
Net cash used in investing activities
|
|
(17,931
|
)
|
|
(122,358
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
|
||||
|
Cash dividends paid to shareholders
|
|
(37,971
|
)
|
|
(31,743
|
)
|
||
|
Net change in revolving credit facility borrowings and overdrafts
|
|
265
|
|
|
1,309
|
|
||
|
Proceeds from issuance of stock under stock plans
|
|
227
|
|
|
913
|
|
||
|
Excess tax benefits on stock-based payments
|
|
8,597
|
|
|
315
|
|
||
|
Purchase of treasury stock
|
|
(10,660
|
)
|
|
(20,122
|
)
|
||
|
Net cash used in financing activities
|
|
(39,542
|
)
|
|
(49,328
|
)
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
|
(8,887
|
)
|
|
(228
|
)
|
||
|
Net change in cash and cash equivalents
|
|
(34,884
|
)
|
|
(136,921
|
)
|
||
|
Cash and cash equivalents at beginning of year
|
|
478,573
|
|
|
405,505
|
|
||
|
Cash and cash equivalents at end of period
|
|
$
|
443,689
|
|
|
$
|
268,584
|
|
|
Interest paid, net of amounts capitalized
|
|
$
|
19,697
|
|
|
$
|
20,033
|
|
|
Income taxes paid
|
|
$
|
20,634
|
|
|
$
|
18,681
|
|
|
|
4
|
|
|
|
5
|
|
|
|
Three Months Ended March 31,
|
||||
|
(SHARES IN THOUSANDS)
|
2015
|
|
2014
|
||
|
Basic
|
80,654
|
|
|
81,053
|
|
|
Assumed dilution under stock plans
|
541
|
|
|
679
|
|
|
Diluted
|
81,195
|
|
|
81,732
|
|
|
(DOLLARS IN THOUSANDS)
|
Employee-Related Costs
|
|
Accelerated Depreciation
|
|
Other
|
|
Total
|
||||||||
|
December 31, 2014
|
$
|
759
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
759
|
|
|
Additional charges, net
|
—
|
|
|
—
|
|
|
187
|
|
|
187
|
|
||||
|
Non-cash charges
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Payments and other costs
|
(258
|
)
|
|
—
|
|
|
(187
|
)
|
|
(445
|
)
|
||||
|
March 31, 2015
|
$
|
501
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
501
|
|
|
|
March 31,
|
|
December 31,
|
||||
|
(DOLLARS IN THOUSANDS)
|
2015
|
|
2014
|
||||
|
Gross carrying value
(1)
|
$
|
218,676
|
|
|
$
|
218,676
|
|
|
Accumulated amortization
|
(143,959
|
)
|
|
(142,119
|
)
|
||
|
Total
|
$
|
74,717
|
|
|
$
|
76,557
|
|
|
(1)
|
Includes patents, trademarks, technological know-how and other intellectual property, valued at acquisition.
|
|
|
6
|
|
|
(DOLLARS IN THOUSANDS)
|
Rate
|
|
Maturities
|
|
March 31, 2015
|
|
December 31, 2014
|
|||||
|
Senior notes - 2007
|
6.40
|
%
|
|
2017-27
|
|
$
|
500,000
|
|
|
$
|
500,000
|
|
|
Senior notes - 2006
|
6.14
|
%
|
|
2016
|
|
125,000
|
|
|
125,000
|
|
||
|
Senior notes - 2013
|
3.20
|
%
|
|
2023
|
|
299,789
|
|
|
299,782
|
|
||
|
Bank overdrafts and other
|
|
|
|
|
14,032
|
|
|
12,335
|
|
|||
|
Deferred realized gains on interest rate swaps
|
|
|
|
|
4,728
|
|
|
5,205
|
|
|||
|
|
|
|
|
|
943,549
|
|
|
942,322
|
|
|||
|
Less: Current portion of long-term debt
|
|
|
|
|
(8,379
|
)
|
|
(8,090
|
)
|
|||
|
|
|
|
|
|
$
|
935,170
|
|
|
$
|
934,232
|
|
|
|
|
7
|
|
|
|
Three Months Ended March 31,
|
||||||
|
(DOLLARS IN THOUSANDS)
|
2015
|
|
2014
|
||||
|
Equity-based awards
|
$
|
5,387
|
|
|
$
|
4,695
|
|
|
Liability-based awards
|
1,907
|
|
|
1,245
|
|
||
|
Total stock-based compensation expense
|
7,294
|
|
|
5,940
|
|
||
|
Less: tax benefit
|
(2,187
|
)
|
|
(1,726
|
)
|
||
|
Total stock-based compensation expense, after tax
|
$
|
5,107
|
|
|
$
|
4,214
|
|
|
|
8
|
|
|
|
Three Months Ended March 31,
|
||||||
|
(DOLLARS IN THOUSANDS)
|
2015
|
|
2014
|
||||
|
Net sales:
|
|
|
|
||||
|
Flavors
|
$
|
377,108
|
|
|
$
|
366,505
|
|
|
Fragrances
|
397,799
|
|
|
403,719
|
|
||
|
Consolidated
|
$
|
774,907
|
|
|
$
|
770,224
|
|
|
Segment profit:
|
|
|
|
||||
|
Flavors
|
$
|
92,727
|
|
|
$
|
88,063
|
|
|
Fragrances
|
81,598
|
|
|
87,166
|
|
||
|
Global expenses
|
(11,564
|
)
|
|
(16,435
|
)
|
||
|
Restructuring and other charges, net
|
(187
|
)
|
|
(122
|
)
|
||
|
Acquisition and related costs
(1)
|
(500
|
)
|
|
—
|
|
||
|
Operational improvement initiative costs
(2)
|
(281
|
)
|
|
(2,619
|
)
|
||
|
Operating profit
|
161,793
|
|
|
156,053
|
|
||
|
Interest expense
|
(11,095
|
)
|
|
(11,677
|
)
|
||
|
Other income (expense), net
|
5,710
|
|
|
(1,443
|
)
|
||
|
Income before taxes
|
$
|
156,408
|
|
|
$
|
142,933
|
|
|
(1)
|
Acquisition and related costs are associated with the acquisition of Henry H. Ottens Manufacturing Co., Inc., as discussed in Note 13.
|
|
(2)
|
Operational improvement initiative costs relate to the closing of a smaller facility in Europe and certain manufacturing activities in Asia, while transferring production to larger facilities in each respective region.
|
|
|
9
|
|
|
U.S. Plans
|
Three Months Ended March 31,
|
||||||
|
(DOLLARS IN THOUSANDS)
|
2015
|
|
2014
|
||||
|
Service cost for benefits earned
|
$
|
984
|
|
|
$
|
885
|
|
|
Interest cost on projected benefit obligation
|
5,953
|
|
|
6,232
|
|
||
|
Expected return on plan assets
|
(8,083
|
)
|
|
(6,913
|
)
|
||
|
Net amortization and deferrals
|
5,203
|
|
|
4,255
|
|
||
|
Net periodic benefit cost
|
4,057
|
|
|
4,459
|
|
||
|
Defined contribution and other retirement plans
|
2,135
|
|
|
2,112
|
|
||
|
Total expense
|
$
|
6,192
|
|
|
$
|
6,571
|
|
|
|
|
|
|
||||
|
Non-U.S. Plans
|
Three Months Ended March 31,
|
||||||
|
(DOLLARS IN THOUSANDS)
|
2015
|
|
2014
|
||||
|
Service cost for benefits earned
|
$
|
4,383
|
|
|
$
|
3,948
|
|
|
Interest cost on projected benefit obligation
|
6,392
|
|
|
8,412
|
|
||
|
Expected return on plan assets
|
(12,950
|
)
|
|
(12,481
|
)
|
||
|
Net amortization and deferrals
|
3,486
|
|
|
2,955
|
|
||
|
Loss due to settlements and special terminations
|
—
|
|
|
—
|
|
||
|
Net periodic benefit cost
|
1,311
|
|
|
2,834
|
|
||
|
Defined contribution and other retirement plans
|
1,595
|
|
|
1,177
|
|
||
|
Total expense
|
$
|
2,906
|
|
|
$
|
4,011
|
|
|
|
Three Months Ended March 31,
|
||||||
|
(DOLLARS IN THOUSANDS)
|
2015
|
|
2014
|
||||
|
Service cost for benefits earned
|
$
|
300
|
|
|
$
|
323
|
|
|
Interest cost on projected benefit obligation
|
1,082
|
|
|
1,238
|
|
||
|
Net amortization and deferrals
|
(711
|
)
|
|
(978
|
)
|
||
|
Total postretirement benefit expense
|
$
|
671
|
|
|
$
|
583
|
|
|
•
|
Level 1–Quoted prices for
identical
instruments in active markets.
|
|
•
|
Level 2–Quoted prices for
similar
instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.
|
|
|
10
|
|
|
•
|
Level 3–Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable
.
|
|
|
March 31, 2015
|
|
December 31, 2014
|
||||||||||||
|
|
Carrying
Amount |
|
Fair
Value |
|
Carrying
Amount |
|
Fair
Value |
||||||||
|
(DOLLARS IN THOUSANDS)
|
|
|
|
|
|
|
|
||||||||
|
Cash and cash equivalents
(1)
|
$
|
443,689
|
|
|
$
|
443,689
|
|
|
$
|
478,573
|
|
|
$
|
478,573
|
|
|
Credit facilities and bank overdrafts
(2)
|
14,032
|
|
|
14,032
|
|
|
12,335
|
|
|
12,335
|
|
||||
|
Long-term debt:
(3)
|
|
|
|
|
|
|
|
||||||||
|
Senior notes - 2007
|
500,000
|
|
|
591,713
|
|
|
500,000
|
|
|
587,650
|
|
||||
|
Senior notes - 2006
|
125,000
|
|
|
131,786
|
|
|
125,000
|
|
|
133,137
|
|
||||
|
Senior notes - 2013
|
299,789
|
|
|
304,294
|
|
|
299,782
|
|
|
296,290
|
|
||||
|
(1)
|
The carrying amount of cash and cash equivalents approximates fair value due to the short maturity of those instruments.
|
|
(2)
|
The carrying amount of our credit facilities and bank overdrafts approximates fair value as the interest rate is reset frequently based on current market rates as well as the short maturity of those instruments.
|
|
(3)
|
The fair value of our long-term debt was calculated using discounted cash flows applying current interest rates and current credit spreads based on our own credit risk.
|
|
|
11
|
|
|
(DOLLARS IN THOUSANDS)
|
March 31, 2015
|
|
December 31, 2014
|
||||
|
Foreign currency contracts
|
$
|
297,050
|
|
|
$
|
191,150
|
|
|
Interest rate swaps
|
$
|
425,000
|
|
|
$
|
425,000
|
|
|
|
March 31, 2015
|
||||||||||
|
(DOLLARS IN THOUSANDS)
|
Fair Value of
Derivatives Designated as Hedging Instruments |
|
Fair Value of
Derivatives Not Designated as Hedging Instruments |
|
Total Fair
Value |
||||||
|
Derivative assets
(a)
|
|
|
|
|
|
||||||
|
Foreign currency contracts
|
$
|
31,972
|
|
|
$
|
17,693
|
|
|
$
|
49,665
|
|
|
Interest rate swaps
|
2,676
|
|
|
—
|
|
|
2,676
|
|
|||
|
|
$
|
34,648
|
|
|
$
|
17,693
|
|
|
$
|
52,341
|
|
|
Derivative liabilities
(b)
|
|
|
|
|
|
||||||
|
Foreign currency contracts
|
$
|
1,193
|
|
|
$
|
9,362
|
|
|
$
|
10,555
|
|
|
|
$
|
1,193
|
|
|
$
|
9,362
|
|
|
$
|
10,555
|
|
|
|
December 31, 2014
|
||||||||||
|
(DOLLARS IN THOUSANDS)
|
Fair Value of
Derivatives Designated as Hedging Instruments |
|
Fair Value of
Derivatives Not Designated as Hedging Instruments |
|
Total Fair
Value |
||||||
|
Derivative assets
(a)
|
|
|
|
|
|
||||||
|
Foreign currency contracts
|
$
|
16,637
|
|
|
$
|
4,398
|
|
|
$
|
21,035
|
|
|
Interest rate swaps
|
683
|
|
|
—
|
|
|
683
|
|
|||
|
|
$
|
17,320
|
|
|
$
|
4,398
|
|
|
$
|
21,718
|
|
|
Derivative liabilities
(b)
|
|
|
|
|
|
||||||
|
Foreign currency contracts
|
$
|
6
|
|
|
$
|
1,055
|
|
|
$
|
1,061
|
|
|
(a)
|
Derivative assets are recorded to Prepaid expenses and other current assets in the Consolidated Balance Sheet.
|
|
(b)
|
Derivative liabilities are recorded as Other current liabilities in the Consolidated Balance Sheet.
|
|
|
|||||||||
|
Derivatives Not Designated as Hedging Instruments
|
Amount of Gain (Loss)
Recognized in Income on Derivative |
|
Location of Gain (Loss)
Recognized in Income
on Derivative
|
||||||
|
|
Three Months Ended March 31,
|
|
|
||||||
|
|
2015
|
|
2014
|
|
|
||||
|
Foreign currency contracts
|
$
|
9,704
|
|
|
$
|
(2,926
|
)
|
|
Other (income) expense, net
|
|
|
12
|
|
|
|
Amount of (Loss) Gain
Recognized in OCI on
Derivative (Effective
Portion)
|
|
Location of (Loss) Gain
Reclassified from AOCI into
Income (Effective Portion)
|
|
Amount of (Loss) Gain
Reclassified from
Accumulated OCI into
Income (Effective
Portion)
|
||||||||||||
|
|
Three Months Ended March 31,
|
|
|
|
Three Months Ended March 31,
|
||||||||||||
|
|
2015
|
|
2014
|
|
|
|
2015
|
|
2014
|
||||||||
|
Derivatives in Cash Flow Hedging Relationships:
|
|
|
|
|
|
|
|
|
|
||||||||
|
Foreign currency contracts
|
12,014
|
|
|
391
|
|
|
Cost of goods sold
|
|
1,023
|
|
|
(753
|
)
|
||||
|
Interest rate swaps
(1)
|
69
|
|
|
69
|
|
|
Interest expense
|
|
(69
|
)
|
|
(69
|
)
|
||||
|
Derivatives in Net Investment Hedging Relationships:
|
|
|
|
|
|
|
|
|
|
||||||||
|
Foreign currency contracts
|
4,561
|
|
|
(375
|
)
|
|
N/A
|
|
—
|
|
|
—
|
|
||||
|
Total
|
$
|
16,644
|
|
|
$
|
85
|
|
|
|
|
$
|
954
|
|
|
$
|
(822
|
)
|
|
|
13
|
|
|
|
Foreign
Currency
Translation
Adjustments
|
|
(Losses) Gains on
Derivatives
Qualifying as
Hedges
|
|
Pension and
Postretirement
Liability
Adjustment
|
|
Total
|
||||||||
|
(DOLLARS IN THOUSANDS)
|
|
|
|
|
|
|
|
||||||||
|
Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2014
|
$
|
(173,342
|
)
|
|
$
|
12,371
|
|
|
$
|
(379,459
|
)
|
|
$
|
(540,430
|
)
|
|
OCI before reclassifications
|
(50,515
|
)
|
|
13,037
|
|
|
—
|
|
|
(37,478
|
)
|
||||
|
Amounts reclassified from AOCI
|
—
|
|
|
(954
|
)
|
|
5,547
|
|
|
4,593
|
|
||||
|
Net current period other comprehensive income (loss)
|
(50,515
|
)
|
|
12,083
|
|
|
5,547
|
|
|
(32,885
|
)
|
||||
|
Accumulated other comprehensive (loss) income, net of tax, as of March 31, 2015
|
$
|
(223,857
|
)
|
|
$
|
24,454
|
|
|
$
|
(373,912
|
)
|
|
$
|
(573,315
|
)
|
|
|
Foreign
Currency
Translation
Adjustments
|
|
(Losses) Gains on
Derivatives
Qualifying as
Hedges
|
|
Pension and
Postretirement
Liability
Adjustment
|
|
Total
|
||||||||
|
(DOLLARS IN THOUSANDS)
|
|
|
|
|
|
|
|
||||||||
|
Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2013
|
$
|
(104,278
|
)
|
|
$
|
(4,012
|
)
|
|
$
|
(284,421
|
)
|
|
$
|
(392,711
|
)
|
|
OCI before reclassifications
|
(9,396
|
)
|
|
(361
|
)
|
|
—
|
|
|
(9,757
|
)
|
||||
|
Amounts reclassified from AOCI
|
—
|
|
|
821
|
|
|
4,365
|
|
|
5,186
|
|
||||
|
Net current period other comprehensive income (loss)
|
(9,396
|
)
|
|
460
|
|
|
4,365
|
|
|
(4,571
|
)
|
||||
|
Accumulated other comprehensive (loss) income, net of tax, as of March 31, 2014
|
$
|
(113,674
|
)
|
|
$
|
(3,552
|
)
|
|
$
|
(280,056
|
)
|
|
$
|
(397,282
|
)
|
|
|
14
|
|
|
|
Three Months Ended March 31, 2015
|
|
Three Months Ended March 31, 2014
|
|
Affected Line Item in the
Consolidated Statement of Comprehensive Income |
||||
|
(DOLLARS IN THOUSANDS)
|
|
|
|
|
|
||||
|
(Losses) gains on derivatives qualifying as hedges
|
|
|
|
|
|
||||
|
Foreign currency contracts
|
1,169
|
|
|
(1,038
|
)
|
|
Cost of goods sold
|
||
|
Interest rate swaps
|
(69
|
)
|
|
(69
|
)
|
|
Interest expense
|
||
|
|
(146
|
)
|
|
286
|
|
|
Provision for income taxes
|
||
|
|
$
|
954
|
|
|
$
|
(821
|
)
|
|
Total, net of income taxes
|
|
(Losses) gains on pension and postretirement liability adjustments
|
|
|
|
|
|
||||
|
Prior service cost
|
1,166
|
|
|
1,111
|
|
|
(a)
|
||
|
Actuarial losses
|
(9,144
|
)
|
|
(7,343
|
)
|
|
(a)
|
||
|
|
2,431
|
|
|
1,867
|
|
|
Provision for income taxes
|
||
|
|
$
|
(5,547
|
)
|
|
$
|
(4,365
|
)
|
|
Total, net of income taxes
|
|
(a)
|
The amortization of prior service cost and actuarial loss is included in the computation of net periodic benefit cost. Refer to Note 13 of our
2014
Form 10-K for additional information regarding net periodic benefit cost.
|
|
|
15
|
|
|
|
16
|
|
|
|
17
|
|
|
|
18
|
|
|
|
19
|
|
|
|
Three Months Ended March 31,
|
|
|
|||||||
|
(DOLLARS IN THOUSANDS
EXCEPT PER SHARE AMOUNTS)
|
2015
|
|
2014
|
|
Change
|
|||||
|
Net sales
|
$
|
774,907
|
|
|
$
|
770,224
|
|
|
1
|
%
|
|
Cost of goods sold
|
428,630
|
|
|
428,812
|
|
|
—
|
%
|
||
|
Gross profit
|
346,277
|
|
|
341,412
|
|
|
|
|||
|
Research and development (R&D) expenses
|
63,462
|
|
|
61,504
|
|
|
3
|
%
|
||
|
Selling and administrative (S&A) expenses
|
120,835
|
|
|
123,733
|
|
|
(2
|
)%
|
||
|
Restructuring and other charges, net
|
187
|
|
|
122
|
|
|
53
|
%
|
||
|
Operating profit
|
161,793
|
|
|
156,053
|
|
|
|
|||
|
Interest expense
|
11,095
|
|
|
11,677
|
|
|
(5
|
)%
|
||
|
Other expense (income), net
|
(5,710
|
)
|
|
1,443
|
|
|
(496
|
)%
|
||
|
Income before taxes
|
156,408
|
|
|
142,933
|
|
|
|
|||
|
Taxes on income
|
28,150
|
|
|
36,226
|
|
|
(22
|
)%
|
||
|
Net income
|
$
|
128,258
|
|
|
$
|
106,707
|
|
|
20
|
%
|
|
Diluted EPS
|
$
|
1.57
|
|
|
$
|
1.30
|
|
|
21
|
%
|
|
Gross margin
|
44.7
|
%
|
|
44.3
|
%
|
|
40
|
|
||
|
R&D as a percentage of sales
|
8.2
|
%
|
|
8.0
|
%
|
|
20
|
|
||
|
S&A as a percentage of sales
|
15.6
|
%
|
|
16.1
|
%
|
|
(50
|
)
|
||
|
Operating margin
|
20.9
|
%
|
|
20.3
|
%
|
|
60
|
|
||
|
Adjusted operating margin
(1)
|
21.0
|
%
|
|
20.6
|
%
|
|
40
|
|
||
|
Effective tax rate
|
18.0
|
%
|
|
25.3
|
%
|
|
(730
|
)
|
||
|
Segment net sales
|
|
|
|
|
|
|||||
|
Flavors
|
$
|
377,108
|
|
|
$
|
366,505
|
|
|
3
|
%
|
|
Fragrances
|
397,799
|
|
|
403,719
|
|
|
(1
|
)%
|
||
|
Consolidated
|
$
|
774,907
|
|
|
$
|
770,224
|
|
|
|
|
|
(1)
|
Adjusted operating margin excludes the Restructuring and other charges, net of $0.2 million, operational improvement initiative costs of $0.3 million and acquisition and related costs of $0.5 million for the
three
months ended
March 31, 2015
and excludes $2.7 million of restructuring and operational improvement initiative costs for the three months ended
March 31, 2014
.
|
|
|
20
|
|
|
|
|
% Change in Sales-First Quarter 2015 vs. First Quarter 2014
|
||||||||||||||||
|
|
|
Fine Fragrances
|
|
Consumer Fragrances
|
|
Ingredients
|
|
Total Frag.
|
|
Flavors
|
|
Total
|
||||||
|
NOAM
|
Reported
|
-14
|
%
|
|
5
|
%
|
|
-20
|
%
|
|
-6
|
%
|
|
10
|
%
|
|
2
|
%
|
|
EAME
|
Reported
|
-13
|
%
|
|
-1
|
%
|
|
-8
|
%
|
|
-7
|
%
|
|
-4
|
%
|
|
-6
|
%
|
|
|
Currency Neutral
(1)
|
-1
|
%
|
|
13
|
%
|
|
0
|
%
|
|
6
|
%
|
|
9
|
%
|
|
7
|
%
|
|
LA
|
Reported
|
-1
|
%
|
|
13
|
%
|
|
1
|
%
|
|
9
|
%
|
|
15
|
%
|
|
11
|
%
|
|
|
Currency Neutral
(1)
|
2
|
%
|
|
16
|
%
|
|
-4
|
%
|
|
11
|
%
|
|
21
|
%
|
|
14
|
%
|
|
GA
|
Reported
|
36
|
%
|
|
2
|
%
|
|
8
|
%
|
|
3
|
%
|
|
0
|
%
|
|
2
|
%
|
|
|
Currency Neutral
(1)
|
38
|
%
|
|
3
|
%
|
|
17
|
%
|
|
6
|
%
|
|
4
|
%
|
|
5
|
%
|
|
Total
|
Reported
|
-10
|
%
|
|
4
|
%
|
|
-8
|
%
|
|
-1
|
%
|
|
3
|
%
|
|
1
|
%
|
|
|
Currency Neutral
(1)
|
-2
|
%
|
|
9
|
%
|
|
-2
|
%
|
|
5
|
%
|
|
9
|
%
|
|
6
|
%
|
|
(1)
|
Currency neutral sales growth is calculated by translating prior year sales at the exchange rates for the corresponding
2015
period.
|
|
•
|
NOAM Flavors sales increased
10%
as a result of double-digit gains in Beverage, Sweet and Dairy. NOAM Fragrance sales decreased
6%
in the
first
quarter of
2015
, principally due to double-digit declines in Fine Fragrance and Ingredients, that were only partially offset by double-digit growth in Home Care and high single-digit growth in Fabric Care categories.
|
|
•
|
EAME Flavors currency neutral sales growth of
9%
was led by double-digit growth in Beverage, high single-digit growth in Sweet and mid single-digit growth in Savory. EAME Fragrance currency neutral sales increased
6%
overall, driven mainly by double-digit growth in Fabric Care and Home Care categories, which were only partially offset by low single-digit declines in Fine Fragrance.
|
|
•
|
LA Flavors currency neutral sales were up
21%
driven by double-digit gains in the Beverage, Sweet, Dairy and Savory categories. LA Fragrances currency neutral sales increased
11%
overall, principally led by double-digit gains in Fabric Care and Home Care, which more than offset double-digit declines in Personal Wash and single-digit declines in Fragrance Ingredients.
|
|
•
|
GA Flavors had currency neutral sales growth of
4%
principally from double-digit gains in Beverage and high single-digit gains in Savory. GA Fragrances currency neutral sales growth of
6%
was principally driven by double-digit growth in Fragrance Ingredients as well as the Personal Wash, Toiletries and Fine Fragrance categories. In addition, the Hair Care and Home Care categories experienced mid to high single-digit growth.
|
|
|
21
|
|
|
|
Three Months Ended March 31,
|
||||||
|
(DOLLARS IN THOUSANDS)
|
2015
|
|
2014
|
||||
|
Segment profit:
|
|
|
|
||||
|
Flavors
|
$
|
92,727
|
|
|
$
|
88,063
|
|
|
Fragrances
|
81,598
|
|
|
87,166
|
|
||
|
Global
|
(11,564
|
)
|
|
(16,435
|
)
|
||
|
Restructuring and other charges, net
|
(187
|
)
|
|
(122
|
)
|
||
|
Acquisition and related costs
|
(500
|
)
|
|
—
|
|
||
|
Operational improvement initiative costs
|
(281
|
)
|
|
(2,619
|
)
|
||
|
Operating profit
|
$
|
161,793
|
|
|
$
|
156,053
|
|
|
Profit margin
|
|
|
|
||||
|
Flavors
|
24.6
|
%
|
|
24.0
|
%
|
||
|
Fragrances
|
20.5
|
%
|
|
21.6
|
%
|
||
|
Consolidated
|
20.9
|
%
|
|
20.3
|
%
|
||
|
|
22
|
|
|
|
23
|
|
|
|
24
|
|
|
(1)
|
Adjusted EBITDA and Net Debt, which are non-GAAP measures used for these covenants, are calculated in accordance with the definition in the debt agreements. In this context, these measures are used solely to provide information on the extent to which we are in compliance with debt covenants and may not be comparable to adjusted EBITDA and Net Debt used by other companies. Reconciliations of adjusted EBITDA to net income and net debt to total debt are as follows:
|
|
|
Twelve Months Ended March 31,
|
||||||
|
(DOLLARS IN MILLIONS)
|
2015
|
|
2014
|
||||
|
Net income
|
$
|
436.1
|
|
|
$
|
369.5
|
|
|
Interest expense
|
45.5
|
|
|
47.3
|
|
||
|
Income taxes
|
126.4
|
|
|
131.1
|
|
||
|
Depreciation and amortization
|
86.6
|
|
|
86.6
|
|
||
|
Specified items
(1)
|
1.4
|
|
|
2.3
|
|
||
|
Non-cash items
(2)
|
20.4
|
|
|
6.6
|
|
||
|
Adjusted EBITDA
|
$
|
716.4
|
|
|
$
|
643.4
|
|
|
(1)
|
Specified items for the 12 months ended
March 31, 2015
of $1.4 million consist of restructuring charges.
|
|
(2)
|
Non-cash items, defined as part of Adjusted EBITDA in the terms of the Company’s credit facility agreement dated November 9, 2011 and amended and restated on April 4, 2014, represent all other adjustments to reconcile net income to net cash provided by operations as presented on the Statement of Cash Flows, including gain on disposal of assets, stock-based compensation and pension settlement/curtailment.
|
|
|
March 31,
|
||||||
|
(DOLLARS IN MILLIONS)
|
2015
|
|
2014
|
||||
|
Total debt
|
$
|
943.5
|
|
|
$
|
933.9
|
|
|
Adjustments:
|
|
|
|
||||
|
Deferred gain on interest rate swaps
|
(4.7
|
)
|
|
(6.6
|
)
|
||
|
Cash and cash equivalents
|
(443.7
|
)
|
|
(268.6
|
)
|
||
|
Net debt
|
$
|
495.1
|
|
|
$
|
658.7
|
|
|
|
25
|
|
|
•
|
volatility and increases in the price of raw materials, energy and transportation;
|
|
•
|
the economic and political risks associated with the Company’s international operations;
|
|
•
|
the Company's ability to benefit from its investments and expansion in emerging markets;
|
|
•
|
fluctuations in the quality and availability of raw materials;
|
|
•
|
our ability to successfully execute acquisitions, collaborations and joint ventures;
|
|
•
|
changes in consumer preferences and demand for the Company's products or decline in consumer confidence and spending;
|
|
•
|
the Company’s ability to implement its business strategy, including the achievement of anticipated cost savings, profitability, realization of price increases and growth targets;
|
|
•
|
the Company’s ability to successfully develop new and competitive products that appeal to its customers and consumers;
|
|
•
|
the impact of a disruption in the Company's supply chain or its relationship with its suppliers;
|
|
•
|
the Company's ability to successfully manage inventory and working capital;
|
|
•
|
the effects of any unanticipated costs and construction or start-up delays in the expansion of any of the Company’s facilities;
|
|
•
|
the impact of currency fluctuations or devaluations in the Company’s principal foreign markets;
|
|
•
|
any adverse impact on the availability, effectiveness and cost of the Company’s hedging and risk management strategies;
|
|
•
|
uncertainties regarding the outcome of, or funding requirements, related to litigation or settlement of pending litigation, uncertain tax positions or other contingencies;
|
|
•
|
the impact of possible pension funding obligations and increased pension expense, particularly as a result of changes in asset returns or discount rates, on the Company’s cash flow and results of operations;
|
|
•
|
the Company’s ability to optimize it's manufacturing facilities, including the achievement of expected cost savings and increased efficiencies;
|
|
•
|
the effect of legal and regulatory proceedings, as well as restrictions imposed on the Company, its operations or its representatives by U.S. and foreign governments;
|
|
•
|
adverse changes in federal, state, local and foreign tax legislation or adverse results of tax audits, assessments, or disputes;
|
|
•
|
the Company's ability to attract and retain talented employees;
|
|
•
|
the direct and indirect costs and other financial impact that may result from any business disruptions due to political instability, armed hostilities, incidents of terrorism, natural disasters, or the responses to or repercussion from any of these or similar events or conditions;
|
|
•
|
the Company’s ability to quickly and effectively implement its disaster recovery and crisis management plans; and
|
|
•
|
adverse changes due to accounting rules or regulations.
|
|
|
26
|
|
|
|
Operating Profit
|
|
% Change - Reported (GAAP)
|
4%
|
|
Items impacting comparability
(1)
|
-2%
|
|
% Change - Adjusted (Non-GAAP)
|
2%
|
|
Currency Impact
|
7%
|
|
% Change - Currency Neutral Adjusted (Non-GAAP)**
|
10%*
|
|
|
27
|
|
|
Item 1.
|
Legal Proceedings
|
|
|
28
|
|
|
|
29
|
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
Period
|
Total Number of
Shares
Repurchased
(1)
|
|
Average
Price Paid
per Share
|
|
Total Number of
Shares Purchased as
Part of Publicly
Announced Program
|
|
Approximate Dollar Value
of Shares That May Yet
be Purchased Under the
Program
|
||||||
|
January 1 - 31, 2015
|
51,435
|
|
|
$
|
102.07
|
|
|
51,435
|
|
|
$
|
103,683,793
|
|
|
February 1 - 28, 2015
|
21,235
|
|
|
111.80
|
|
|
21,235
|
|
|
101,309,657
|
|
||
|
March 1 - 31, 2015
|
25,443
|
|
|
119.34
|
|
|
25,443
|
|
|
98,273,281
|
|
||
|
Total
|
98,113
|
|
|
$
|
108.65
|
|
|
98,113
|
|
|
$
|
98,273,281
|
|
|
(1)
|
Shares were repurchased pursuant to the repurchase program announced in December 2012, with repurchases beginning in the first quarter of 2013. Repurchases under the program are limited to $250 million in total repurchase price, and the expiration date is December 31, 2016. Authorization of the repurchase program may be modified, suspended, or discontinued at any time.
|
|
Item 6.
|
Exhibits
|
|
3.2
|
|
Amended and Restated Bylaws of the Company, effective as of May 6, 2015, incorporated by reference to Exhibit 3.2 to the Company’s Report on Form 8-K filed on May 6, 2015
|
|
10.1
|
|
2015 Stock Award and Incentive Plan, incorporated by reference to Annex 1 of the Company’s definitive proxy statement on Schedule 14A filed with the SEC on March 18, 2015
|
|
10.2
|
|
Amended and Restated Executive Severance Policy, as amended through and including March 11, 2015
|
|
10.3
|
|
Form of Annual Incentive Plan Award Agreement under the International Flavors & Fragrances 2015 Stock Award and Incentive Plan
|
|
10.4
|
|
Form of Long-Term Incentive Plan Award Agreement under the International Flavors & Fragrances 2015 Stock Award and Incentive Plan
|
|
10.5
|
|
Form of Equity Choice Program Award Agreement under the International Flavors & Fragrances 2015 Stock Award and Incentive Plan
|
|
10.6
|
|
Form of Restricted Stock Units Award Agreement under the International Flavors & Fragrances 2015 Stock Award and Incentive Plan
|
|
10.7
|
|
Form of Non-Employee Director Restricted Stock Units Award Agreement under the International Flavors & Fragrances 2015 Stock Award and Incentive Plan
|
|
10.8
|
|
2010 Stock Award and Incentive Plan, as Amended and Restated as of May 6, 2015
|
|
31.1
|
|
Certification of Andreas Fibig pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2
|
|
Certification of Richard A. O'Leary pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32
|
|
Certification of Andreas Fibig and Richard A. O'Leary pursuant to 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002.
|
|
101.INS
|
|
XBRL Instance Document
|
|
101.SCH
|
|
XBRL Taxonomy Extensions Schema
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
30
|
|
|
Dated:
|
|
May 12, 2015
|
By:
|
|
/s/ Andreas Fibig
|
|
|
|
|
|
|
Andreas Fibig
|
|
|
|
|
|
|
Chairman of the Board and Chief Executive Officer
|
|
|
|
|
|
|
|
|
Dated:
|
|
May 12, 2015
|
By:
|
|
/s/ Richard A. O'Leary
|
|
|
|
|
|
|
Richard A. O'Leary
|
|
|
|
|
|
|
Interim Chief Financial Officer, Vice President and Controller
|
|
|
31
|
|
|
Number
|
|
Description
|
|
3.2
|
|
Amended and Restated Bylaws of the Company, effective as of May 6, 2015, incorporated by reference to Exhibit 3.2 to the Company’s Report on Form 8-K filed on May 6, 2015
|
|
10.1
|
|
2015 Stock Award and Incentive Plan, incorporated by reference to Annex 1 of the Company’s definitive proxy statement on Schedule 14A filed with the SEC on March 18, 2015
|
|
10.2
|
|
Amended and Restated Executive Severance Policy, as amended through and including March 11, 2015
|
|
10.3
|
|
Form of Annual Incentive Plan Award Agreement under the International Flavors & Fragrances 2015 Stock Award and Incentive Plan
|
|
10.4
|
|
Form of Long-Term Incentive Plan Award Agreement under the International Flavors & Fragrances 2015 Stock Award and Incentive Plan
|
|
10.5
|
|
Form of Equity Choice Program Award Agreement under the International Flavors & Fragrances 2015 Stock Award and Incentive Plan
|
|
10.6
|
|
Form of Restricted Stock Units Award Agreement under the International Flavors & Fragrances 2015 Stock Award and Incentive Plan
|
|
10.7
|
|
Form of Non-Employee Director Restricted Stock Units Award Agreement under the International Flavors & Fragrances 2015 Stock Award and Incentive Plan
|
|
10.8
|
|
2010 Stock Award and Incentive Plan, as Amended and Restated as of May 6, 2015
|
|
31.1
|
|
Certification of Andreas Fibig pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2
|
|
Certification of Richard A. O'Leary pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32
|
|
Certification of Andreas Fibig and Richard A. O'Leary pursuant to 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002.
|
|
101.INS
|
|
XBRL Instance Document
|
|
101.SCH
|
|
XBRL Taxonomy Extensions Schema
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
32
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| The Estée Lauder Companies Inc. | EL |
| L Brands, Inc. | LB |
| Revlon, Inc. | REV |
Suppliers
| Supplier name | Ticker |
|---|---|
| Stepan Company | SCL |
| Sensient Technologies Corporation | SXT |
| Tredegar Corporation | TG |
| Flotek Industries, Inc. | FTK |
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|